Credit Suisse Ag Blue Water Vaccines Inc. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$2.13 - $63.0 $14,271 - $422,100
6,700 New
6,700 $14,000

Others Institutions Holding BWV

# of Institutions
1
Shares Held
53.6K
Call Options Held
0
Put Options Held
0
View Full List

About Blue Water Vaccines Inc.

BWV Quotes by TradingView
  • Ticker BWV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,744,900
  • Market Cap $2.34M
  • Description
  • Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical de...
More about BWV
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email